Comparative Immunogenicities of Frozen and Refrigerated Formulations of Live Attenuated Influenza Vaccine in Healthy Subjects

Por Block, Stan L., Reisinger, Keith S., Hultquist, Micki, Walker, Robert E.
Publicado em 2007

A dose-ranging study of MF59(®)-adjuvanted and non-adjuvanted A/H1N1 pandemic influenza vaccine in young to middle-aged and older adult populations to assess safety, immunogenicity...

Por Reisinger, Keith S, Holmes, Sandra J, Pedotti, Paola, Arora, Ashwani Kumar, Lattanzi, Maria
Publicado no Hum Vaccin Immunother (2014)

Quadrivalent Meningococcal Vaccination of Adults: Phase III Comparison of an Investigational Conjugate Vaccine, MenACWY-CRM, with the Licensed Vaccine, Menactra

Por Reisinger, Keith S., Baxter, Roger, Block, Stanley L., Shah, Jina, Bedell, Lisa, Dull, Peter M.
Publicado em 2009

Safety and tolerability of zoster vaccine in adults ≥60 years old

Por Murray, Alexander V., Reisinger, Keith S., Kerzner, Boris, Stek, Jon E., Sausser, Timothy A., Xu, Jin, Wang, William W., Chan, Ivan S.F., Annunziato, Paula W., Parrino, Janie
Publicado em 2011

Immunogenicity and Safety of an Inactivated Quadrivalent Influenza Vaccine Candidate: A Phase III Randomized Controlled Trial in Children

Por Langley, Joanne M., Carmona Martinez, Alfonso, Chatterjee, Archana, Halperin, Scott A., McNeil, Shelly, Reisinger, Keith S., Aggarwal, Naresh, Huang, Li-Min, Peng, Ching-Tien, Garcia-Sicilia, José, Salamanca de la Cueva, Ignacio, Cabañas, Fernando, Treviño-Garza, Consuelo, Rodríguez-Weber, Miguel Angel, de la O, Manuel, Chandrasekaran, Vijayalakshmi, Dewé, Walthère, Liu, Aixue, Innis, Bruce L., Jain, Varsha K.
Publicado em 2013